Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of different viral biomarkers on the management of chronic hepatitis B
Lung‐Yi Mak, Rex Wan‐Hin Hui, James Fung, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 263-276
Open Access | Times Cited: 19

Showing 19 citing articles:

Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 4, pp. 851-868
Open Access | Times Cited: 23
ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B
Ryan Hin-Man Leung, Rex Wan‐Hin Hui, Lung‐Yi Mak, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 218-226
Closed Access | Times Cited: 10
Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies
Ivana Lazarević, Ana Banko, Danijela Miljanovic, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 46-46
Open Access | Times Cited: 8
Hepatitis B core-related antigen as a promising serological marker for monitoring hepatitis B virus cure
Yue Qiu, Qiao Tang, Xiaoqing Liu, et al.
World Journal of Hepatology (2025) Vol. 17, Iss. 1
Closed Access
Development and Validation of a High‐Sensitivity Droplet Digital PCR Assay for Serum Hepatitis B Virus DNA Detection
Rex Wan‐Hin Hui, Danny Ka‐Ho Wong, Lung‐Yi Mak, et al.
Journal of Viral Hepatitis (2025) Vol. 32, Iss. 4
Open Access
Functional Cure for Hepatitis B Virus: Challenges and Achievements
Oren Shechter, Daniel Sausen, Harel Dahari, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3633-3633
Open Access
Unraveling Demographic Patterns in Hepatitis B Clinical and Laboratory Profiles: Insights From a Ghanaian Cohort: A Retrospective Study
Napoleon Bellua Sam, Saeed F. Majeed, Adams Dramani
Health Science Reports (2025) Vol. 8, Iss. 4
Open Access
Editorial: High qHBsAg—is it a good or bad signal?
Beom Kyung Kim
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 12, pp. 1616-1617
Open Access | Times Cited: 2
Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind
Beom Kyung Kim
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 656-658
Open Access | Times Cited: 2
Opportunities and challenges for hepatitis B cure
Armando Andres Roca Suarez, Fabien Zoulim
eGastroenterology (2023) Vol. 1, Iss. 2, pp. e100021-e100021
Open Access | Times Cited: 5
Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis
Qi‐Hang Cao, Hui Liu, Lun‐Jie Yan, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 8, pp. 1464-1475
Open Access | Times Cited: 1
Class II Transactivator Restricts Viral Replication, Extending its Effect to HBV
Cho-Rong Lee, Sung‐Gyoo Park
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 724-727
Open Access | Times Cited: 1
Extended analysis on peripheral blood cytokines correlated with hepatitis B virus viral load in chronically infected patients – a systematic review and meta-analysis
Marina Manea, Ion Mărunţelu, Ileana Constantinescu
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Investigational RNA Interference Agents for Hepatitis B
Rex Wan‐Hin Hui, Lung‐Yi Mak, Wai‐Kay Seto, et al.
BioDrugs (2024)
Open Access | Times Cited: 1
Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
Joo Hyun Oh, Dong Hyun Sinn
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 367-370
Open Access | Times Cited: 3
CD4+ T cell counts and soluble programmed death-1 at baseline correlated with hepatitis B surface antigen decline in HIV/HBV coinfection during combined antiretroviral therapy
Xiaodi Li, Ling Xu, Lianfeng Lu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 2
Non-Invasive Prediction Scores for Hepatitis B Virus- and Hepatitis D Virus-Infected Patients—A Cohort from the North-Eastern Part of Romania
Laura Iulia Grecu, Camelia Sultana, Mariana Pavel, et al.
Microorganisms (2023) Vol. 11, Iss. 12, pp. 2895-2895
Open Access | Times Cited: 2
Linvencovir: Paving the way for functional cure in hepatitis B
Jiwon Yang, Jonggi Choi
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 164-165
Open Access
Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis
Hyun‐Jae Shin, Won‐Mook Choi, Seung Up Kim, et al.
JHEP Reports (2024) Vol. 6, Iss. 7, pp. 101089-101089
Open Access
Current perspectives of viral hepatitis
Daisuke Usuda, Yuki Kaneoka, R Ono, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 18, pp. 2402-2417
Open Access
Page 1

Scroll to top